Patents by Inventor Yayoi KISHIMOTO

Yayoi KISHIMOTO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC AGENT FOR COVID-19
    Publication number: 20230390235
    Abstract: The present invention aims to develop a method for treating COVID-19 caused by SARS-CoV-2 or a mutant strain thereof, and provides an agent for preventing and/or treating COVID-19 caused by SARS-CoV-2 or a mutant strain thereof, the agent comprising a specific compound.
    Type: Application
    Filed: October 29, 2021
    Publication date: December 7, 2023
    Applicants: SENJU PHARMACEUTICAL CO., LTD., TOHOKU UNIVERSITY
    Inventors: Mitsuyoshi AZUMA, Chiho FUKIAGE, Takashi IMADA, Yayoi KISHIMOTO, Noriyasu HIRASAWA, Yoshiro SAITO, Takashi TOYAMA
  • RETINAL GANGLION CELL DEATH INHIBITOR
    Publication number: 20210346386
    Abstract: The present invention relates to a retinal ganglion cell death suppressor comprising a BMPR signal transduction inhibitor, a drug comprising a BMPR signal transduction inhibitor for protecting retinal neurons, and a pharmaceutical composition using these for preventing or treating a disease involving retinal ganglion cell death, such as glaucoma, diabetic retinopathy and retinal vascular occlusion.
    Type: Application
    Filed: October 28, 2019
    Publication date: November 11, 2021
    Applicant: SENJU PHARMACEUTICAL CO., LTD.
    Inventors: Yayoi KISHIMOTO, Chiho YABUTA